W
Weng L
Publications - 1
Citations - 1221
Weng L is an academic researcher. The author has contributed to research in topics: Antigen & Immunotherapy. The author has an hindex of 1, co-authored 1 publications receiving 840 citations.
Papers
More filters
Journal ArticleDOI
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown,Darya Alizadeh,Renate Starr,Weng L,Wagner,Araceli Naranjo,Ostberg,Melvin Blanchard,Kilpatrick J,Simpson J,Kurien A,Saul J. Priceman,Xiuli Wang,Harshbarger Tl,Massimo D'Apuzzo,Ressler Ja,Michael C. Jensen,Michael E. Barish,Chen M,Jana Portnow,Stephen J. Forman,Behnam Badie +21 more
TL;DR: Recurrent multifocal glioblastoma patients received chimeric antigen receptor (CAR)-engineered T cells targeting the tumor-associated antigen interleukin-13 receptor alpha 2 (IL13Rα2) and regression of all intracranial and spinal tumors was observed, along with corresponding increases in levels of cytokines and immune cells in the cerebrospinal fluid.